AbbVie (ABBV) Assets Average (2013 - 2026)

AbbVie has disclosed Assets Average across 14 years of filings, most recently posting $135.2 billion for Q1 2026.

• In Q1 2026, Assets Average changed 0.33% year-over-year to $135.2 billion; the TTM figure through Mar 2026 stood at $135.2 billion (changed 0.33% YoY), while the FY2025 annual figure was $134.6 billion, changed 0.28% from the prior year.
• Assets Average climbed to $135.2 billion in Q1 2026, from $133.9 billion in the prior quarter.
• Over the last five years, Assets Average for ABBV reached as high as $145.4 billion in Q2 2024 and fell as low as $133.9 billion in Q4 2025.
• The 5-year median for Assets Average is $136.7 billion (2023), against an average of $138.8 billion.
• Annual changes were most pronounced in 2024 — Assets Average gained 7.74% — and 2025, when it slipped 6.01%.
• A 5-year view of Assets Average shows it stood at $140.1 billion in 2022, then dropped by 3.28% to $135.5 billion in 2023, then climbed by 2.82% to $139.3 billion in 2024, then declined by 3.85% to $133.9 billion in 2025, then grew by 0.96% to $135.2 billion in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $135.2 billion, $133.9 billion, and $135.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.